Certolizumab Human Monoclonal Antibody
Certolizumabis a research-grade recombinant antibody targeting CD2. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
TNF, Tumor necrosis factor ligand superfamily member 2, N-terminal fragment, ICD2, NTF, TNF-a, TNF-alpha, Tumor necrosis factor, TNFSF2, TNFA, Cachectin, ICD1
UniProt
P01375
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein L purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human Humanized
Preservative
0.01M PBS, pH 7.4.
Isotype
Fab'-IgG1-kappa
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15391228 1 Vial
Lentiviral human KRT25 sgRNA gene knockout kit - Lentiviral human KRT25 sgRNA gene knockout kit (100)
Sign In for Pricing
View Details ![(2s) -2-{[ (benzyloxy) carbonyl]amino}-3- (3,4-dihydroxyphenyl) propanoic acid](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
OR1042431-01 50 mg
(2s) -2-{[ (benzyloxy) carbonyl]amino}-3- (3,4-dihydroxyphenyl) propanoic acid
Sign In for Pricing
View Details